Detalhe da pesquisa
1.
What is the best treatment strategy before autologous peripheral blood stem cell transplantation in POEMS syndrome?
Haematologica
; 109(3): 888-894, 2024 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37646655
2.
Carfilzomib combined with lenalidomide and dexamethasone (KRd) as salvage therapy for multiple myeloma patients: italian, multicenter, retrospective clinical experience with 600 cases outside of controlled clinical trials.
Hematol Oncol
; 40(5): 1009-1019, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-35638723
3.
Adjusted comparison between elotuzumab and carfilzomib in combination with lenalidomide and dexamethasone as salvage therapy for multiple myeloma patients.
Eur J Haematol
; 108(3): 178-189, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34716957
4.
Role of serum-free light chain assay for defining response and progression in immunoglobulin secretory multiple myeloma.
Am J Hematol
; 97(12): 1607-1615, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36198076
5.
Monoclonal gammopathy of renal significance (MGRS): Real-world data on outcomes and prognostic factors.
Am J Hematol
; 97(7): 877-884, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35389534
6.
Identification of a Maturation Plasma Cell Index through a Highly Sensitive Droplet Digital PCR Assay Gene Expression Signature Validation in Newly Diagnosed Multiple Myeloma Patients.
Int J Mol Sci
; 23(20)2022 Oct 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-36293315
7.
A real-world efficacy and safety analysis of combined carfilzomib, lenalidomide, and dexamethasone (KRd) in relapsed/refractory multiple myeloma.
Hematol Oncol
; 39(1): 41-50, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33085797
8.
Novel agent-based salvage autologous stem cell transplantation for relapsed multiple myeloma.
Ann Hematol
; 96(12): 2071-2078, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-29063955
9.
Bortezomib-based therapy combined with high cut-off hemodialysis is highly effective in newly diagnosed multiple myeloma patients with severe renal impairment.
Am J Hematol
; 90(7): 647-52, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25858483
10.
HIF-1α inhibition blocks the cross talk between multiple myeloma plasma cells and tumor microenvironment.
Exp Cell Res
; 328(2): 444-55, 2014 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25257607
11.
Bortezomib and dexamethasone as salvage therapy in patients with relapsed/refractory multiple myeloma: analysis of long-term clinical outcomes.
Ann Hematol
; 93(1): 123-8, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23864035
12.
Bortezomib- and thalidomide-induced peripheral neuropathy in multiple myeloma: clinical and molecular analyses of a phase 3 study.
Am J Hematol
; 89(12): 1085-91, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25159313
13.
Severe SARS-CoV-2 and subsequent fungal infections after CAR T-cell therapy for relapsed/refractory multiple myeloma: a challenging and happy ending fight.
Leuk Res Rep
; 21: 100399, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38078287
14.
Multi-dimensional scaling techniques unveiled gain1q&loss13q co-occurrence in Multiple Myeloma patients with specific genomic, transcriptional and adverse clinical features.
Nat Commun
; 15(1): 1551, 2024 Feb 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38378709
15.
Single-Cell DNA Sequencing Reveals an Evolutionary Pattern of CHIP in Transplant Eligible Multiple Myeloma Patients.
Cells
; 13(8)2024 Apr 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38667272
16.
Safety and efficacy of daratumumab in dialysis-dependent renal failure secondary to multiple myeloma.
Haematologica
; 103(6): e277-e278, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29622654
17.
Treatment optimization for multiple myeloma: schedule-dependent synergistic cytotoxicity of pomalidomide and carfilzomib in in vitro and ex vivo models.
Haematologica
; 103(12): e602-e606, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30026343
18.
High levels of CRBN isoform lacking IMiDs binding domain predicts for a worse response to IMiDs-based upfront therapy in newly diagnosed myeloma patients.
Clin Exp Med
; 23(8): 5227-5239, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37815734
19.
Long term follow-up of humoral and cellular response to mRNA-based vaccines for SARS-CoV-2 in patients with active multiple myeloma.
Front Oncol
; 13: 1208741, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37305577
20.
Role of serum free light chain assay in the detection of early relapse and prediction of prognosis after relapse in multiple myeloma patients treated upfront with novel agents.
Haematologica
; 102(3): e104-e107, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-27909220